Belfast-based health technogoly company B-Secur said today that it has completed a total raise of £8.8m of investment in 2021.
The latest round was led by US-based First Capital Ventures, while Bank of Ireland's Kernel Capital Growth Fund NI increased its investment level to £2.2m with other existing investors also participating.
B-Secur has developed a world first software technique that uses a person's unique heartbeat pattern, known as electrocardiogram (ECG) in everyday technologies to securely identify, and provide health and wellness insights at the same time.
Medical grade ECG recording traditionally happens in the hospital environment using expensive equipment, but B-Secur are embedding this into latest smartwatches, cars and even clothing and are already selling to some of the world's largest technology companies.
B-Secur was granted FDA clearance for its technology late last year and has since signed its first contract with a US based medical device manufacturer.
The company, which has offices within Belfast's Innovation Centre, Catalyst, employs over 45 scientists and engineers and will look to hire additional staff in Belfast and the US with the new funding.
"We are delighted with the investment by First Capital Ventures and by the continued support from Kernel Capital and our other investors and we look forward to a transformational 2022 when our technology will be embedded across both consumer and medical devices," commented Alan Foreman, CEO of B-Secur.
"The world class team at B-Secur has demonstrated that their patented and FDA cleared technology delivers insights and value to wellness and medical devices alike. Kernel Capital are pleased to continue our strong support of the company as it accelerates its growth," Siggi Saevarsson, Partner at Kernel Capital, said today.
